Development of highly porous calcium phosphate bone cements applying nonionic surface active agents

Current methods for creating porous calcium phosphate cements have limitations in achieving sufficient porosity without compromising structural integrity. Prior research has shown that foaming techniques can enhance porosity, but the role of nonionic surfactants in this process remains underexplored. It was already known that surfactants influence foam stability and porosity in cement systems. However, the specific effects of different nonionic surfactants on both physical and biological properties of the cement were not well established. This gap motivated the investigation of three distinct surfactants to determine their impact on cement performance. No prior work had resolved how surfactant type affects both porosity and cytotoxicity in these materials. The need for a reliable method to produce bioactive, porous cements for bone regeneration remains a key challenge in the field. This study aimed to address these uncertainties by systematically evaluating surfactant-assisted foaming approaches.

The study aimed to develop a method for producing highly porous calcium phosphate cements using nonionic surfactants. The specific problem addressed was the lack of understanding about how different surfactants influence both the physical and biological properties of the cements. The motivation stemmed from the need for materials that can mimic cancellous bone structure while maintaining bioactivity. The researchers proposed to investigate three surfactants—Tween 20, Tween 80, and Tetronic 90R4—to determine their effects on porosity and cytotoxicity. A key goal was to identify surfactant concentrations that avoid cytotoxic effects while maximizing porosity. The study also sought to evaluate the compressive strength of the resulting materials. The ultimate objective was to establish a surfactant-assisted foaming process that supports in situ bone cement applications. This approach could potentially advance the design of scaffolds for tissue engineering.

The study employed a surfactant-assisted foaming process to fabricate calcium phosphate cements. Three nonionic surfactants were selected based on their chemical properties and prior use in similar applications. The amount of surfactant was determined using critical micelle concentration and cytotoxicity data. The foaming method involved mixing the surfactant with the cement liquid phase before casting. The resulting foamed cements were analyzed for porosity and compressive strength. In vitro tests were conducted to assess chemical stability and bioactivity. Cytotoxicity was evaluated by measuring cell viability in the presence of cement extracts. The materials were characterized using standard physicochemical techniques. The study compared the performance of cements made with each surfactant to identify optimal formulations.

The highest porosity, exceeding 50 vol%, was observed in cements made with Tween 80. Compressive strength values matched those of cancellous bone, indicating structural suitability. Tetronic 90R4 showed the lowest cytotoxicity at 1.25 g L⁻¹, while Tween 20 exhibited the highest. The surfactant concentration was capped at 1.25 g L⁻¹ to avoid cytotoxic effects. The foaming process successfully produced open-porous structures in all tested materials. In vitro tests confirmed the chemical stability of the cements over time. Bioactive potential was demonstrated through interactions with surrounding tissues. These findings suggest that surfactant choice significantly influences both physical and biological outcomes.

The authors propose that surfactant-assisted foaming is a viable method for producing highly porous calcium phosphate cements. The study suggests that Tween 80 is the most effective surfactant for achieving high porosity and compressive strength. Tetronic 90R4 may offer the best balance between low cytotoxicity and functional performance. The results suggest that surfactant concentration must be carefully controlled to avoid cytotoxic effects. The findings suggest that the developed materials may be suitable for in situ bone cement applications. The study suggests that the foaming method can be adapted for clinical use with appropriate surfactant selection. The authors suggest that further work is needed to validate these materials in vivo. The authors propose that this approach could enhance the design of bioactive scaffolds for tissue engineering.